MODULATING EXPRESSION OF FOXP3 CORRELATES WITH CLINICAL RESPONSE TO INFLIXIMAB: NEW MECHANISM OF ACTION FOR ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE

(1) Lab of Experimental Immunology

(2) UZ.Gastroenterology

(3) Department of Molecular Cell Biology, Catholic University, Leuven, Belgium



This item was part of the IMMFLAMMATORY BOWEL DISEASE II session at Gastro 2009 UEGW/WCOG London (17th UEGW)